Browse by UCL people
Group by: Type | Date
Number of items: 176.
2024
Burchill, E;
Watson, CJ;
Fanshawe, JB;
Badenoch, JB;
Rengasamy, E;
Ghanem, DA;
Holle, C;
... Rogers, JP; + view all
(2024)
The impact of psychiatric comorbidity on Parkinson's disease outcomes: a systematic review and meta-analysis.
The Lancet Regional Health - Europe
, 39
, Article 100870. 10.1016/j.lanepe.2024.100870.
|
Foltynie, Tom;
Bruno, Veronica;
Fox, Susan;
Kühn, Andrea A;
Lindop, Fiona;
Lees, Andrew J;
(2024)
Medical, surgical, and physical treatments for Parkinson's disease.
The Lancet
, 403
(10423)
pp. 305-324.
10.1016/S0140-6736(23)01429-0.
|
Lees, AJ;
Lawson, Sarah;
(2024)
Earworms—A Narrative Review of Infectious Music.
JAMA
, 331
(13)
pp. 1075-1076.
10.1001/jama.2024.2780.
|
Luo, Huihui;
Gustavsson, Emil K;
Macpherson, Hannah;
Dominik, Natalia;
Zhelcheska, Kristina;
Montgomery, Kylie;
Anderson, Claire;
... Chen, Zhongbo; + view all
(2024)
Letter to the editor on: Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions by Park et al. (2022).
Acta Neuropathol Commun
, 12
(1)
, Article 2. 10.1186/s40478-023-01706-7.
|
2023
Langworth-Green, C;
Patel, S;
Jaunmuktane, Z;
Jabbari, E;
Morris, H;
Thom, M;
Lees, A;
... Duff, K; + view all
(2023)
Chronic effects of inflammation on tauopathies.
The Lancet Neurology
, 22
(5)
pp. 430-442.
10.1016/S1474-4422(23)00038-8.
|
Nagy, AV;
Leschziner, G;
Eriksson, SH;
Lees, A;
Noyce, AJ;
Schrag, A;
(2023)
Cognitive impairment in REM-sleep behaviour disorder and individuals at risk of Parkinson's disease.
Parkinsonism and Related Disorders
, 109
, Article 105312. 10.1016/j.parkreldis.2023.105312.
|
Simonet, C;
Mahlknecht, P;
Marini, K;
Seppi, K;
Gill, A;
Bestwick, JP;
Lees, AJ;
... Noyce, AJ; + view all
(2023)
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease.
Movement Disorders
10.1002/mds.29496.
(In press).
|
Street, Duncan;
Jabbari, Edwin;
Costantini, Alyssa;
Jones, P Simon;
Holland, Negin;
Rittman, Timothy;
Jensen, Marte T;
... Rowe, James B; + view all
(2023)
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
Brain
, Article awad105. 10.1093/brain/awad105.
(In press).
|
2022
Barbosa, P;
O'Sullivan, SS;
Joyce, E;
Lees, AJ;
Warner, TT;
Djamshidian, A;
(2022)
Neuropsychiatric Features of Punding and Hobbyism in Parkinson's Disease.
Movement Disorders Clinical Practice
, 9
(1)
pp. 82-86.
10.1002/mdc3.13363.
|
Buechele, F;
Baumann, CR;
Lees, A;
Deuschl, G;
(2022)
Encouraging a Generation of Tremor Researchers: Macdonald Critchley's Paper on Essential Tremor.
Movement Disorders Clinical Practice
, 9
(1)
pp. 38-41.
10.1002/mdc3.13333.
|
Lees, AJ;
(2022)
Le Bal des Folles.
Brain
, 145
(4)
pp. 1564-1568.
10.1093/brain/awac089.
|
Schofield, Christine;
Chaudhuri, K Ray;
Carroll, Camille;
Sharma, Jagdish C;
Pavese, Nicola;
Evans, Jonathan;
Foltynie, Thomas;
... Lees, Andrew; + view all
(2022)
Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease.
Neurodegenerative Disease Management
10.2217/nmt-2021-0057.
(In press).
|
Wright, Isaac Hempstead;
Sekar, Akila;
Jensen, Marte Theilmann;
Hodgson, Megan;
Bancroft, Matthew J;
Koohi, Nehzat;
Lees, Andrew J;
... Kaski, Diego; + view all
(2022)
Reflexive and volitional saccadic eye movements and their changes in age and progressive supranuclear palsy.
Journal of the Neurological Sciences
, 443
, Article 120482. 10.1016/j.jns.2022.120482.
|
2021
Barbosa, P;
Djamshidian, A;
Lees, AJ;
Warner, TT;
(2021)
The prevalence of impulsive compulsive behaviors in patients treated with apomorphine infusion: a retrospective analysis.
Arq Neuropsiquiatr
10.1590/0004-282X-ANP-2020-0522.
(In press).
|
Barbosa, P;
Hapuarachchi, B;
Djamshidian, A;
Strand, K;
Lees, AJ;
de Silva, R;
Holton, JL;
(2021)
Reply to 'Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [11C]-PHNO PET study'.
Parkinsonism & Related Disorders
, 93
pp. 31-32.
10.1016/j.parkreldis.2021.11.003.
|
Barbosa, P;
Lees, AJ;
(2021)
Dopamine devils.
Arquivos de Neuro-Psiquiatria
, 79
(11)
pp. 941-942.
10.1590/0004-282X-ANP-2021-e011.
|
Beckers, M;
Lees, AJ;
Nutt, JG;
Bloem, BR;
(2021)
Turning Back the Clock in Parkinson's Disease: Practical Recommendations for Managing Diurnal Symptom Worsening.
Journal of Parkinson's Disease
10.3233/JPD-212711.
(In press).
|
Bestwick, JP;
Auger, SD;
Simonet, C;
Rees, RN;
Rack, D;
Jitlal, M;
Giovannoni, G;
... Noyce, AJ; + view all
(2021)
Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm.
NPJ Parkinsons Disease
, 7
(1)
p. 33.
10.1038/s41531-021-00176-9.
(In press).
|
Castillo-Torres, SA;
Lees, AJ;
(2021)
Erasing "the purely arbitrary line" intertwining neuroscience, history, and culture with writing.
Archivos de Neurociencias
, 26
(3)
pp. 6-7.
10.31157/archneurosciencesmex.v26i3.318.
|
Jabbari, E;
Koga, S;
Valentino, R;
Reynolds, R;
Ferrari, R;
Tan, M;
Rowe, J;
... Morris, H; + view all
(2021)
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
The Lancet Neurology
, 20
(2)
pp. 107-116.
10.1016/S1474-4422(20)30394-X.
|
Katzenschlager, R;
Poewe, W;
Rascol, O;
Trenkwalder, C;
Deuschl, G;
Chaudhuri, KR;
Henriksen, T;
... Lees, A; + view all
(2021)
Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study.
Parkinsonism and Related Disorders
, 83
pp. 79-85.
10.1016/j.parkreldis.2020.12.024.
|
Lees, AJ;
(2021)
Bird watching on the asphalt.
Brain
, 144
(1)
pp. 2-5.
10.1093/brain/awaa437.
|
Miki, Y;
Tsushima, E;
Foti, SC;
Strand, KM;
Asi, YT;
Yamamoto, AK;
Bettencourt, C;
... Ling, H; + view all
(2021)
Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.
Brain
, 144
(4)
pp. 1138-1151.
10.1093/brain/awab017.
|
Noyce, A;
(2021)
Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features.
npj Parkinson's Disease
, 7
, Article 87. 10.1038/s41531-021-00226-2.
|
Simone, R;
Javad, F;
Emmett, W;
Wilkins, OG;
Almeida, FL;
Barahona-Torres, N;
Zareba-Paslawska, J;
... De Silva, R; + view all
(2021)
MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration.
Nature
, 594
pp. 117-123.
10.1038/s41586-021-03556-6.
|
Simonet, C;
Galmes, M;
Lambert, C;
Rees, R;
Haque, T;
Bestwick, J;
Lees, A;
... Noyce, A; + view all
(2021)
Slow Motion Analysis of Repetitive Tapping (SMART) test: measuring bradykinesia in recently diagnosed Parkinson’s disease and idiopathic anosmia.
Journal of Parkinson's Disease
, 11
(4)
pp. 1901-1915.
10.3233/JPD-212683.
|
Teive, HAG;
Camargo, CHF;
Walusinski, O;
Lees, AJ;
(2021)
Charcot: Buddhist Leanings?
European Neurology
, 84
(2)
pp. 135-138.
10.1159/000514430.
|
Thomas, G;
Zarkali, A;
Ryten, M;
Shmueli, K;
Gil Martinez, A;
Leyland, L;
McColgan, P;
... Weil, R; + view all
(2021)
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease.
Brain
, Article awab084. 10.1093/brain/awab084.
(In press).
|
Tolosa, E;
Ebersbach, G;
Ferreira, JJ;
Rascol, O;
Antonini, A;
Foltynie, T;
Gibson, R;
... Lees, A; + view all
(2021)
The Parkinson's Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson's Disease in Patients and their Carers.
Journal of Parkinson's Disease
, 11
(3)
pp. 1309-1323.
10.3233/JPD-212611.
|
Weil, RS;
Lees, AJ;
(2021)
How to understand it: Visual hallucinations.
Practical Neurology
, 21
(4)
pp. 327-332.
10.1136/practneurol-2021-003016.
|
Zarkali, A;
McColgan, P;
Leyland, L;
Lees, A;
Weil, R;
(2021)
Longitudinal thalamic white and gray matter changes associated with visual hallucinations in Parkinson’s disease.
Journal of Neurology, Neurosurgery and Psychiatry
, 93
pp. 169-179.
10.1136/jnnp-2021-326630.
|
Zarkali, A;
McColgan, P;
Leyland, L;
Lees, A;
Weil, R;
(2021)
Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson’s disease.
Movement Disorders
(In press).
|
Zarkali, A;
McColgan, P;
Leyland, L-A;
Lees, AJ;
Rees, G;
Weil, RS;
(2021)
Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson's disease.
Communications Biology
, 4
, Article 86. 10.1038/s42003-020-01622-9.
|
2020
Alarcón, F;
Maldonado, J-C;
Cañizares, M;
Molina, J;
Noyce, A;
Lees, AJ;
(2020)
Motor Dysfunction as a Prodrome of Parkinson's Disease.
Journal of Parkinson's Disease
10.3233/JPD-191851.
(In press).
|
Ben-Joseph, A;
Marshall, CR;
Lees, AJ;
Noyce, AJ;
(2020)
Ethnic Variation in the Manifestation of Parkinson's Disease: A Narrative Review.
Journal of Parkinson's Disease
, 10
(1)
pp. 31-45.
10.3233/JPD-191763.
|
Chelban, V;
Carecchio, M;
Rea, G;
Bowirrat, A;
Kirmani, S;
Magistrelli, L;
Efthymiou, S;
... Houlden, H; + view all
(2020)
MYORG-related disease is associated with central pontine calcifications and atypical parkinsonism.
Neurology Genetics
, 6
(2)
, Article e399. 10.1212/NXG.0000000000000399.
|
Chen, Z;
Yan Yau, W;
Jaunmuktane, Z;
Tucci, A;
Sivakumar, P;
Gagliano Taliun, SA;
Turner, C;
... Houlden, H; + view all
(2020)
Neuronal intranuclear inclusion disease is genetically heterogeneous.
Annals of Clinical and Translational Neurology
, 7
(9)
pp. 1716-1725.
10.1002/acn3.51151.
|
Fearon, C;
Lees, AJ;
McKinley, JJ;
McCarthy, A;
Smyth, S;
Farrell, M;
Lynch, T;
(2020)
On the Emergence of Tremor in Prodromal Parkinson's Disease.
Journal of Parkinson's Disease
10.3233/JPD-202322.
(In press).
|
Lees, AJ;
(2020)
Lithium: a slow burner.
Journal of Neurology, Neurosurgery, and Psychiatry
, 91
(4)
pp. 335-337.
10.1136/jnnp-2019-322382.
|
Miki, Y;
Foti, SC;
Hansen, D;
Strand, KM;
Asi, YT;
Tsushima, E;
Jaunmuktane, Z;
... Holton, JL; + view all
(2020)
Hippocampal α-synuclein pathology correlates with memory impairment in multiple system atrophy.
Brain
, 143
(6)
pp. 1798-1810.
10.1093/brain/awaa126.
|
Mulroy, E;
Menozzi, E;
Lees, AJ;
Lynch, T;
Lang, AE;
Bhatia, KP;
(2020)
Telemedicine in movement disorders – Leçons du COVID‐19.
Movement Disorders
, 35
(11)
pp. 1893-1896.
10.1002/mds.28297.
|
Mulroy, E;
Menozzi, E;
Lees, AJ;
Lynch, T;
Lang, AE;
Bhatia, KP;
(2020)
Reply to: A New Day: The Role of Telemedicine in Reshaping Care for Persons with Movement Disorders.
Movement Disorders
10.1002/mds.28315.
(In press).
|
Noyce, A;
(2020)
Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank.
Journal of Neurology, Neurosurgery and Psychiatry
, 91
(10)
pp. 1046-1054.
10.1136/jnnp-2020-323646.
|
Orme, T;
Hernandez, D;
Ross, OA;
Kun-Rodrigues, C;
Darwent, L;
Shepherd, CE;
Parkkinen, L;
... Bras, J; + view all
(2020)
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies.
Acta Neuropathologica Communications
, 8
(1)
, Article 5. 10.1186/s40478-020-0879-z.
|
Reichmann, H;
Lees, A;
Rocha, JF;
Magalhães, D;
Soares-Da-Silva, P;
Zolnai, CA;
Bartels, C;
... Schrey, C; + view all
(2020)
Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: The OPTIPARK open-label study.
Translational Neurodegeneration
, 9
(1)
, Article 9. 10.1186/s40035-020-00187-1.
|
Sanotsky, Y;
Selikhova, M;
Fedoryshyn, L;
Kuzyk, P;
Matviyenko, Y;
Semeryak, O;
Dziewulska, D;
... Lees, AJ; + view all
(2020)
Neuropathological Findings in Ephedrone Encephalopathy.
Movement Disorders
10.1002/mds.28125.
(In press).
|
Weil, R;
Thomas, G;
Leyland, L;
Schrag, A;
Lees, A;
Acosta-Cabronero, J;
(2020)
Brain iron deposition is linked with cognitive severity in Parkinson’s disease.
Journal of Neurology, Neurosurgery, and Psychiatry
, 91
(4)
pp. 418-425.
10.1136/jnnp-2019-322042.
|
Weil, R;
Zarkali, A;
McColgan, P;
Leyland, L;
Lees, A;
Rees, G;
(2020)
Fibre-specific white matter reductions in Parkinson’s hallucinations and visual dysfunction.
Neurology
, 94
(14)
e1525-e1538.
10.1212/WNL.0000000000009014.
|
Zarkali, A;
McColgan, P;
Leyland, L-A;
Lees, AJ;
Weil, RS;
(2020)
Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson's disease.
BioRxiv: Cold Spring Harbor, NY, USA.
|
Zarkali, A;
McColgan, P;
Ryten, M;
Reynolds, R;
Leyland, L;
Lees, A;
Rees, G;
(2020)
Differences in network controllability and regional gene expression underlie visual hallucinations in Parkinson’s disease.
Brain: a journal of neurology
, 143
(11)
pp. 3435-3448.
10.1093/brain/awaa270.
|
Zarkali, A;
McColgan, P;
Ryten, M;
Reynolds, R;
Leyland, L;
Lees, A;
Rees, G;
(2020)
Dementia risk in Parkinson’s disease is associated with
interhemispheric connectivity loss and determined by regional
gene expression.
NeuroImage: Clinical
, 28
, Article 102470. 10.1016/j.nicl.2020.102470.
|
2019
Araújo, R;
van de Warrenburg, B;
Lang, A;
Lees, A;
Bloem, B;
(2019)
The Waiting Room: neurological observations made outside the movement disorder specialist's consulting office.
Practical Neurology
, 19
(4)
pp. 295-301.
10.1136/practneurol-2018-002110.
|
Barbosa, P;
Hapuarachchi, B;
Djamshidian, A;
Strand, K;
Lees, AJ;
de Silva, R;
Holton, JL;
(2019)
Lower nucleus accumbens α-synuclein load and D3 receptor levels in Parkinson's disease with impulsive compulsive behaviours.
Brain
, 142
(11)
pp. 3580-3591.
10.1093/brain/awz298.
|
Barbosa, P;
Kaski, D;
Castro, P;
Lees, AJ;
Warner, TT;
Djamshidian, A;
(2019)
Saccadic Direction Errors are Associated with Impulsive Compulsive Behaviours in Parkinson’s Disease Patients.
Journal of Parkinson's Disease
10.3233/jpd-181460.
(In press).
|
Barbosa, PM;
Djamshidian, A;
O'Sullivan, SS;
De Pablo-Fernandez, E;
Korlipara, P;
Morris, HR;
Bhatia, KP;
... Warner, TT; + view all
(2019)
The long-term outcome of impulsive compulsive behaviours in Parkinson's disease.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2018-319891.
(In press).
|
Brittain, C;
McCarthy, A;
Irizarry, MC;
McDermott, D;
Biglan, K;
Hoglinger, GU;
Lorenzl, S;
... Gerpen, JV; + view all
(2019)
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
Parkinsonism & Related Disorders
, 60
pp. 138-145.
10.1016/j.parkreldis.2018.08.025.
|
Castillo-Torres, SA;
Soto-Rincon, CA;
Estrada-Bellmann, I;
Lees, AJ;
(2019)
Will the Real James Parkinson Please Stand Up? Another Fake James Parkinson.
Movement Disorders Clinical Practice
10.1002/mdc3.12722.
(In press).
|
De Pablo Fernandez, E;
Lees, A;
Holton, J;
Warner, T;
(2019)
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease.
JAMA Neurology
10.1001/jamaneurol.2018.4377.
(In press).
|
De Pablo-Fernández, E;
Lees, AJ;
Holton, JL;
Warner, TT;
(2019)
Neuropathological progression of clinical Parkinson disease subtypes.
[Letter].
Nature Reviews Neurology
, 15
, Article 361. 10.1038/s41582-019-0197-x.
|
Ferreira, JJ;
Lees, A;
Rocha, J-F;
Poewe, W;
Rascol, O;
Soares-da-Silva, P;
(2019)
Long‐term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open‐label extensions.
European Journal of Neurology
, 26
(7)
pp. 953-960.
10.1111/ene.13914.
|
Guerreiro, R;
Escott-Price, V;
Hernandez, DG;
Kun-Rodrigues, C;
Ross, OA;
Orme, T;
Neto, JL;
... Bras, J; + view all
(2019)
Heritability and genetic variance of dementia with Lewy bodies.
Neurobiology of Disease
, 127
pp. 492-501.
10.1016/j.nbd.2019.04.004.
|
Hasan, H;
Burrows, M;
Athauda, D;
Hellman, B;
James, B;
Warner, T;
Foltynie, T;
... Noyce, A; + view all
(2019)
The BRadykinesia Akinesia INcoordination (BRAIN) tap test: capturing the sequence effect.
Movement Disorders: Clinical Practice
10.1002/mdc3.12798.
(In press).
|
Jabbari, E;
Holland, N;
Chelban, V;
Jones, PS;
Lamb, R;
Rawlinson, C;
Guo, T;
... Morris, HR; + view all
(2019)
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
JAMA Neurology
, 77
(3)
pp. 377-387.
10.1001/jamaneurol.2019.4347.
|
Jabbari, E;
Woodside, J;
Guo, T;
Magdalinou, NK;
Chelban, V;
Athauda, D;
Lees, AJ;
... Morris, HR; + view all
(2019)
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-320151.
|
Jabbari, E;
Woodside, J;
Tan, MMX;
Pavese, N;
Bandmann, O;
Ghosh, BCP;
Massey, LA;
... Morris, HR; + view all
(2019)
The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy.
Movement Disorders
10.1002/mds.27786.
(In press).
|
Kun-Rodrigues, C;
Orme, T;
Carmona, S;
Hernandez, DG;
Ross, OA;
Eicher, JD;
Shepherd, C;
... Bras, J; + view all
(2019)
A comprehensive screening of copy number variability in dementia with Lewy bodies.
Neurobiology of Aging
, 75
, Article 223.e1-223.e10. 10.1016/j.neurobiolaging.2018.10.019.
|
Lees, A;
Ferreira, JJ;
Rocha, J-F;
Rascol, O;
Poewe, W;
Gama, H;
Soares-da-Silva, P;
(2019)
Safety Profile of Opicapone in the Management of Parkinson's Disease.
Journal of Parkinson's Disease
, 9
(4)
pp. 733-740.
10.3233/JPD-191593.
|
Lees, AJ;
(2019)
Listening with intent.
Practical Neurology
10.1136/practneurol-2019-002307.
(In press).
|
Lees, AJ;
(2019)
Noticing in Neurology.
Practical Neurology
10.1136/practneurol-2018-002176.
(In press).
|
Lees, AJ;
Hurwitz, B;
(2019)
Testing the reflexes.
BMJ
, 366
, Article l4830. 10.1136/bmj.l4830.
|
Lees, AJ;
Swash, M;
(2019)
Face-making: task-specific facial tensions and grimacing in musicians.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(10)
pp. 1180-1182.
10.1136/jnnp-2019-321149.
|
Mainka, T;
Balint, B;
Gövert, F;
Kurvits, L;
van Riesen, C;
Kühn, AA;
Tijssen, MAJ;
... Ganos, C; + view all
(2019)
The spectrum of involuntary vocalizations in humans: A video atlas.
Movement Disorders
10.1002/mds.27855.
|
Oliveira, MCB;
Ling, H;
Lees, AJ;
Holton, JL;
De Pablo-Fernandez, E;
Warner, TT;
(2019)
Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy.
Journal of Neurology, Neurosurgery and Psychiatry
, 90
(5)
pp. 555-561.
10.1136/jnnp-2018-319374.
|
Simonet, C;
Schrag, A;
Lees, AJ;
Noyce, AJ;
(2019)
The motor prodromes of parkinson's disease: from bedside observation to large-scale application.
Journal of Neurology
10.1007/s00415-019-09642-0.
(In press).
|
Weil, R;
Zarkali, A;
Lees, A;
(2019)
Flickering stimuli do not reliably induce visual hallucinations in Parkinson's disease.
Journal of Parkinson's Disease
, 9
(3)
pp. 631-635.
10.3233/JPD-191635.
|
2018
Barbosa, PM;
Djamshidian, A;
Lees, AJ;
Warner, TT;
(2018)
The Outcome of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Retrospective Post Mortem Study.
Movement Disorders Clinical Practice
10.1002/mdc3.12671.
(In press).
|
Barbosa, PM;
Grippe, T;
Lees, AJ;
O'Sullivan, SO;
Djamshidian, A;
Warner, TT;
(2018)
Compulsive sexual behaviour in Parkinson’s disease is associated with higher doses of levodopa.
Journal of Neurology, Neurosurgery & Psychiatry
, 89
(10)
pp. 1121-1123.
10.1136/jnnp-2017-317298.
|
Castillo-Torres, SA;
Estrada-Bellmann, IE;
Lees, AJ;
(2018)
Sir William Osler's 'Influences' for the Successful Physician, A Reappraisal After 126 Years.
Archives of Medical Research
, 49
(6)
pp. 418-420.
10.1016/j.arcmed.2018.11.008.
|
Fabbri, M;
Ferreira, JJ;
Lees, A;
Stocchi, F;
Poewe, W;
Tolosa, E;
Rascol, O;
(2018)
Opicapone for the Treatment of Parkinson's Disease: a Review of a New Licensed Medicine.
Movement Disorders
10.1002/mds.27475.
(In press).
|
Ferreira, JJ;
Lees, AJ;
Poewe, W;
Rascol, O;
Rocha, J-F;
Keller, B;
Soares-da-Silva, P;
(2018)
Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.
Neurology
, 90
(21)
e1849-e1857.
10.1212/WNL.0000000000005557.
|
Fisher, R;
Lincoln, L;
Jackson, MJ;
Abbate, V;
Jenner, P;
Hider, R;
Lees, A;
(2018)
The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease.
Phytotherapy Research
, 32
(4)
pp. 678-687.
10.1002/ptr.6017.
|
Guerreiro, R;
Orme, T;
Neto, JL;
Bras, J;
International DLB Genetics Consortium, .;
(2018)
LRP10 in alpha-synucleinopathies.
Lancet Neurology
, 17
(12)
pp. 1032-1033.
10.1016/S1474-4422(18)30399-5.
|
Guerreiro, R;
Ross, OA;
Kun-Rodrigues, C;
Hernandez, DG;
Orme, T;
Eicher, JD;
Shepherd, CE;
... Bras, J; + view all
(2018)
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.
The Lancet Neurology
, 17
(1)
pp. 64-74.
10.1016/S1474-4422(17)30400-3.
|
Jabbari, E;
Woodside, J;
Tan, MMX;
Shoai, M;
Pittman, A;
Ferrari, R;
Mok, KY;
... Morris, HR; + view all
(2018)
Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.
Annals of Neurology
, 84
(4)
pp. 485-496.
10.1002/ana.25308.
|
Katzenschlager, R;
Poewe, W;
Rascol, O;
Trenkwalder, C;
Deuschl, G;
Chaudhuri, KR;
Henriksen, T;
... Lees, A; + view all
(2018)
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.
The Lancet Neurology
, 17
(9)
pp. 749-759.
10.1016/S1474-4422(18)30239-4.
|
Lees, A;
Eyre, P;
Brown, P;
(2018)
The true face of James Parkinson.
The Lancet Neurology
, 17
(6)
p. 507.
10.1016/S1474-4422(18)30174-1.
|
Lees, AJ;
(2018)
Some reflections on the lasting importance of James Parkinson’s essay on the shaking palsy.
Zhurnal nevrologii i psikhiatrii imeni. S.S. Korsakova
, 118
(1)
pp. 75-76.
10.17116/jnevro20181181175-76.
|
Magdalinou, NK;
Golden, HL;
Nicholas, JM;
Witoonpanich, P;
Mummery, CJ;
Morris, HR;
Djamshidian, A;
... Warren, JD; + view all
(2018)
Verbal adynamia in parkinsonian syndromes: behavioral correlates and neuroanatomical substrate.
Neurocase
, 24
(4)
pp. 204-212.
10.1080/13554794.2018.1527368.
|
Morley, JF;
Cohen, A;
Silveira-Moriyama, L;
Lees, AJ;
Williams, DR;
Katzenschlager, R;
Hawkes, C;
... Duda, JE; + view all
(2018)
Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test.
npj Parkinson's Disease
, 4
, Article 2. 10.1038/s41531-017-0039-8.
|
Noyce, AJ;
Dickson, J;
Rees, RN;
Bestwick, JP;
Isaias, IU;
Politis, M;
Giovannoni, G;
... Schrag, A; + view all
(2018)
Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.
Movement Disorders
, 33
(3)
pp. 478-482.
10.1002/mds.27282.
|
Pessoa, RR;
Moro, A;
Munhoz, RP;
Teive, HAG;
Lees, AJ;
(2018)
Apomorphine in the treatment of Parkinson's disease: a review.
Arquivos de Neuro-Psiquiatria
, 76
(12)
pp. 840-848.
10.1590/0004-282X20180140.
|
Santens, P;
De Letter, M;
Lees, AJ;
Krack, P;
van den Heuvel, OA;
Bloem, BR;
(2018)
Crime and Parkinson's: The jury is out.
Movement Disorders
, 33
(7)
pp. 1092-1094.
10.1002/mds.27436.
|
Silveira-Moriyama, L;
Kovac, S;
Kurian, MA;
Houlden, H;
Lees, AJ;
Walker, MC;
Roze, E;
... Warner, TT; + view all
(2018)
Phenotypes, genotypes, and the management of paroxysmal movement disorders.
Development Medicine and Child Neurology
, 60
(6)
pp. 559-565.
10.1111/dmcn.13744.
|
Silveira-Moriyama, L;
Lees, AJ;
(2018)
Endemic atypical parkinsonism.
Journal of the Neurological Sciences
10.1016/j.jns.2018.02.018.
(In press).
|
Swash, M;
Lees, AJ;
(2018)
Medical conferences: Value for money?
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-319248.
(In press).
|
Teive, HAG;
Germiniani, FMB;
Camargo, CHF;
Walusinski, O;
Lees, AJ;
(2018)
"Flâneur neurologique in paris" – A guide to pinpointing the houses of famous neurologists in the late XIX century.
Journal of Clinical Neuroscience
, 52
pp. 32-36.
10.1016/j.jocn.2018.04.001.
|
Vijiaratnam, N;
Lees, AJ;
Morris, HR;
(2018)
Small spiral, big mass.
Journal of Neurology, Neurosurgery and Psychiatry
, 89
(11)
pp. 1189-1190.
10.1136/jnnp-2018-319019.
|
2017
Athauda, D;
Maclagan, K;
Skene, SS;
Bajwa-Joseph, M;
Letchford, D;
Chowdhury, K;
Hibbert, S;
... Foltynie, T; + view all
(2017)
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
The Lancet
, 390
(10103)
pp. 1664-1675.
10.1016/S0140-6736(17)31585-4.
|
Boes, CJ;
Toodayan, N;
Lees, A;
(2017)
Finding the grave of Sir William Richard Gowers.
Practical Neurology
, 17
(4)
pp. 321-322.
10.1136/practneurol-2017-001648.
|
De Pablo-Fernandez, E;
Tur, C;
Revesz, T;
Lees, AJ;
Holton, JL;
Warner, TT;
(2017)
Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.
JAMA Neurology
, 74
(8)
pp. 970-976.
10.1001/jamaneurol.2017.1125.
|
Enriquez-Marulanda, A;
Sierra-Ruiz, M;
Jaramillo, FJ;
Escobar, LA;
Granados, AM;
Rodríguez-Rojas, LX;
Lees, AJ;
(2017)
Hemichoreo-hemibalism as a Manifestation of Central Nervous System Chronic Graft-versus-Host Disease.
Movement Disorders Clinical Practice
, 4
(4)
pp. 495-498.
10.1002/mdc3.12497.
|
Geissler, JM;
International Parkinson Disease Genomics Consortium members;
Romanos, M;
Gerlach, M;
Berg, D;
Schulte, C;
(2017)
No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease in nine ADHD candidate SNPs.
ADHD Attention Deficit and Hyperactivity Disorders
, 9
(2)
pp. 121-127.
10.1007/s12402-017-0219-8.
|
Hansson, O;
Janelidze, S;
Hall, S;
Magdalinou, N;
Lees, AJ;
Andreasson, U;
Norgren, N;
... Swedish BioFINDER Study, .; + view all
(2017)
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Neurology
, 88
(10)
pp. 930-937.
10.1212/WNL.0000000000003680.
|
Jansen, IE;
Ye, H;
Heetveld, S;
Lechler, MC;
Michels, H;
Seinstra, RI;
Lubbe, SJ;
... Heutink, P; + view all
(2017)
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.
Genome Biology
, 18
, Article 22. 10.1186/s13059-017-1147-9.
|
Kempster, PA;
Hurwitz, B;
Lees, AJ;
(2017)
James Parkinson’s chimera: Syndrome or disease?
Journal of the Royal College of Physicians of Edinburgh
, 47
(2)
pp. 190-195.
10.4997/JrCPe.2017.220.
|
Kun-Rodrigues, C;
Ross, OA;
Orme, T;
Shepherd, C;
Parkkinen, L;
Darwent, L;
Hernandez, D;
... Bras, J; + view all
(2017)
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.
Neurobiology of Aging
, 49
214.e13-214.e15.
10.1016/j.neurobiolaging.2016.08.023.
|
Lees, A;
(2017)
Dorsal column grey matter an essay on the shaking palsy.
Brain
, 140
(3)
pp. 843-848.
10.1093/brain/awx035.
|
Lees, AJ;
(2017)
From Sgt. Pepper to Dreamachines: My Scientific Odyssey With William S. Burroughs.
JAMA
, 318
(22)
pp. 2164-2166.
10.1001/jama.2017.17914.
|
Lees, AJ;
(2017)
William Burroughs: Sailor of the Soul.
Journal of Psychoactive Drugs
, 49
(5)
pp. 385-392.
10.1080/02791072.2017.1357862.
|
Lees, AJ;
Ferreira, J;
Rascol, O;
Poewe, W;
Rocha, J-F;
McCrory, M;
Soares-da-Silva, P;
(2017)
Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.
JAMA Neurology
, 74
(2)
pp. 197-206.
10.1001/jamaneurol.2016.4703.
|
Lees, AJ;
Ferreira, J;
Rascol, O;
Reichmann, H;
Stocchi, F;
Tolosa, E;
Poewe, W;
(2017)
Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA.
Expert Review of Neurotherapeutics
, 17
(7)
pp. 649-659.
10.1080/14737175.2017.1336086.
|
Ling, H;
Morris, HR;
Neal, JW;
Lees, A;
Hardy, J;
Holton, JL;
Revesz, T;
(2017)
Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired Association football (soccer) players.
Acta Neuropathologica
, 133
(3)
pp. 337-352.
10.1007/s00401-017-1680-3.
|
Magdalinou, NK;
Noyce, AJ;
Pinto, R;
Lindstrom, E;
Holmen-Larsson, J;
Holtta, M;
Blennow, K;
... Gobom, J; + view all
(2017)
Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.
Parkinsonism & Related Disorders
, 37
pp. 65-71.
10.1016/j.parkreldis.2017.01.016.
|
Massey, LA;
Miranda, MA;
Al-Helli, O;
Parkes, HG;
Thornton, JS;
So, PW;
White, MJ;
... Yousry, TA; + view all
(2017)
9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.
NeuroImage: Clinical
, 13
pp. 154-163.
10.1016/j.nicl.2016.11.015.
|
Noyce, AJ;
Kia, DA;
Hemani, G;
Nicolas, A;
Price, TR;
De Pablo-Fernandez, E;
Haycock, PC;
... Wood, NW; + view all
(2017)
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.
PLoS Medicine
, 14
(6)
, Article e1002314. 10.1371/journal.pmed.1002314.
|
Noyce, AJ;
Lees, A;
(2017)
Observations on a 2-Step Approach to Screening for Parkinson Disease.
JAMA Neurology
, 74
(12)
, Article 1506. 10.1001/jamaneurol.2017.3202.
|
Noyce, AJ;
R'Bibo, L;
Peress, L;
Bestwick, JP;
Adams-Carr, KL;
Mencacci, NE;
Hawkes, CH;
... Schrag, A; + view all
(2017)
PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.
Movement Disorders
, 32
(2)
pp. 219-226.
10.1002/mds.26898.
|
Pakpoor, J;
Noyce, A;
Goldacre, R;
Selkihova, M;
Mullin, S;
Schrag, A;
Lees, A;
(2017)
Viral hepatitis and Parkinson disease: A national record-linkage study.
Neurology
, 88
(17)
pp. 1630-1633.
10.1212/WNL.0000000000003848.
|
Pedroso, JL;
Linden, SC;
Barsottini, OG;
Maranhão, P;
Lees, AJ;
(2017)
The relationship between the First World War and neurology: 100 years of "Shell Shock".
Arquivos de Neuro-Psiquiatria
, 75
(5)
pp. 317-319.
10.1590/0004-282X20170046.
|
Robak, LA;
Jansen, IE;
van Rooij, J;
Uitterlinden, AG;
Kraaij, R;
Jankovic, J;
Heutink, P;
(2017)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
Brain
, 140
(12)
pp. 3191-3203.
10.1093/brain/awx285.
|
Teive, HA;
Barbosa, ER;
Lees, AJ;
(2017)
Wilson's disease: the 60th anniversary of Walshe's article on treatment with penicillamine.
Arquivos de Neuro-Psiquiatria
, 75
(1)
pp. 69-71.
10.1590/0004-282X20160166.
|
Teive, HAG;
Lees, AJ;
(2017)
Georges Simenon, Inspector Maigret and his relevance to the practice of Neurology.
Arquivos de Neuro-Psiquiatria
, 75
(3)
pp. 189-191.
10.1590/0004-282X20170019.
|
Teive, HAG;
Munhoz, RP;
Lees, AJ;
(2017)
Parkinson's disease - 200 years: the outstanding contribution of "Old Hubert".
Arquivos de Neuro-Psiquiatria
, 75
(3)
pp. 192-194.
10.1590/0004-282X20170006.
|
Warner, TT;
Lees, A;
Barbosa, P;
Magee, C;
Djamshidian, A;
(2017)
A retrospective evaluation of the frequency of impulsive compulsive behaviours in Parkinson’s disease patients treated with continuous waking day apomorphine pumps.
Movement Disorders Clinical Practice
, 4
(3)
pp. 323-328.
10.1002/mdc3.12416.
|
Weil, RS;
McColgan, P;
Schrag, AE;
Warren, JD;
Crutch, SJ;
Lees, AJ;
Morris, HR;
(2017)
Reply: MRI findings of visual system alterations in Parkinson's disease.
Brain
, 140
(11)
e70.
10.1093/brain/awx245.
|
Witoelar, A;
Jansen, IE;
Wang, Y;
Desikan, RS;
Gibbs, JR;
Blauwendraat, C;
Thompson, WK;
... International Parkinson’s Disease Genomics Consortium (IPDGC), N, .; + view all
(2017)
Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.
JAMA Neurology
, 74
(7)
pp. 780-792.
10.1001/jamaneurol.2017.0469.
|
2016
Adams-Carr, KL;
Bestwick, JP;
Shribman, S;
Lees, A;
Schrag, A;
Noyce, AJ;
(2016)
Constipation preceding Parkinson's disease: a systematic review and meta-analysis.
J Neurol Neurosurg Psychiatry
, 87
(7)
pp. 710-716.
10.1136/jnnp-2015-311680.
|
Bang, J;
Lobach, IV;
Lang, AE;
Grossman, M;
Knopman, DS;
Miller, BL;
Schneider, LS;
... AL-108-231 Investigators, .; + view all
(2016)
Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.
Parkinsonism & Related Disorders
, 28
pp. 41-48.
10.1016/j.parkreldis.2016.04.014.
|
Borgemeester, RW;
Lees, AJ;
van Laar, T;
(2016)
Parkinson's disease, visual hallucinations and apomorphine: a review of the available evidence.
Parkinsonism & Related Disorders
, 27
pp. 35-40.
10.1016/j.parkreldis.2016.04.023.
|
Doherty, KM;
De Pablo-Fernandez, E;
Houlden, H;
Polke, JM;
Lees, AJ;
Warner, TT;
Holton, JL;
(2016)
MSA-C or SCA 17? A clinicopathological case update.
Movement Disorders
, 31
(10)
pp. 1582-1584.
10.1002/mds.26741.
|
Guerreiro, R;
Escott-Price, V;
Darwent, L;
Parkkinen, L;
Ansorge, O;
Hernandez, DG;
Nalls, MA;
... Bras, J; + view all
(2016)
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.
Neurobiology of Aging
, 38
214.e7-214.e10.
10.1016/j.neurobiolaging.2015.10.028.
|
Hewer, S;
Varley, S;
Boxer, AL;
Paul, E;
Williams, DR;
AL-108-231 Investigators;
(2016)
Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale.
Movement Disorders
, 31
(10)
pp. 1574-1577.
10.1002/mds.26694.
|
Lamb, R;
Rohrer, JD;
Lees, AJ;
Morris, HR;
(2016)
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.
Current Treatment Options in Neurology
, 18
(9)
, Article 42. 10.1007/s11940-016-0422-5.
|
Mok, KY;
Sheerin, U;
Simón-Sánchez, J;
Salaka, A;
Chester, L;
Escott-Price, V;
Mantripragada, K;
... Wood, NW; + view all
(2016)
Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.
Lancet Neurology
, 15
(6)
pp. 585-596.
10.1016/S1474-4422(16)00071-5.
|
Moriyama, TS;
Chagas, MHN;
Silveira-Moriyama, L;
Tumas, V;
Lees, AJ;
Crippa, JA;
Bressan, RA;
(2016)
Diagnosing social anxiety in Parkinson’s disease: Characteristics and frequencies according to two diagnostic criteria.
Revista de Psiquiatria Clinica
, 43
(6)
pp. 139-142.
10.1590/0101-60830000000100.
|
Noyce, AJ;
Lees, AJ;
Schrag, AE;
(2016)
The prediagnostic phase of Parkinson's disease.
Journal of Neurology, Neurosurgery and Psychiatry
, 87
(8)
pp. 871-878.
10.1136/jnnp-2015-311890.
|
Noyce, AJ;
Schrag, A;
Masters, JM;
Bestwick, JP;
Giovannoni, G;
Lees, AJ;
(2016)
Subtle motor disturbances in PREDICT-PD participants.
Journal of Neurology, Neurosurgery and Psychiatry
, 88
pp. 212-217.
10.1136/jnnp-2016-314524.
|
Sailer, A;
Scholz, SW;
Nalls, MA;
Schulte, C;
Federoff, M;
Price, TR;
Lees, A;
... European Multiple System Atrophy Study Group and the UK Multiple; + view all
(2016)
A genome-wide association study in multiple system atrophy.
Neurology
, 87
(15)
pp. 1591-1598.
10.1212/WNL.0000000000003221.
|
Selikhova, M;
Tripoliti, E;
Fedoryshyn, L;
Matvienko, Y;
Stanetska, H;
Boychuk, M;
Komnatska, I;
... Sanotsky, Y; + view all
(2016)
Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse.
Clinical Neurology and Neurosurgery
, 147
pp. 71-77.
10.1016/j.clineuro.2016.05.027.
|
Tsai, RM;
Lobach, I;
Bang, J;
Whitwell, JL;
Senjem, ML;
Jack, CR;
Rosen, H;
... AL-108-231 Investigators; + view all
(2016)
Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
Parkinsonism & Related Disorders
, 28
pp. 29-35.
10.1016/j.parkreldis.2016.04.006.
|
Weil, RS;
Schrag, AE;
Warren, JD;
Crutch, SJ;
Lees, AJ;
Morris, HR;
(2016)
Visual dysfunction in Parkinson's disease.
Brain
10.1093/brain/aww175.
(In press).
|
2015
Kiely, AP;
Ling, H;
Asi, YT;
Kara, E;
Proukakis, C;
Schapira, AH;
Morris, HR;
... Holton, JL; + view all
(2015)
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.
Molecular Neurodegeneration
, 10
, Article 41. 10.1186/s13024-015-0038-3.
|
Ling, H;
Kearney, S;
Yip, HL;
Silveira-Moriyama, L;
Revesz, T;
Holton, JL;
Strand, C;
... Lees, AJ; + view all
(2015)
Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?
J Neurol Neurosurg Psychiatry
10.1136/jnnp-2015-310756.
|
Noyce, AJ;
Mencacci, NE;
Schrag, A;
Bestwick, JP;
Giovannoni, G;
Lees, AJ;
Hardy, J;
(2015)
Web-based assessment of Parkinson's prodromal markers identifies GBA variants.
Mov Disord
, 30
(7)
pp. 1002-1003.
10.1002/mds.26249.
|
Schottlaender, LV;
Polke, JM;
Ling, H;
MacDoanld, ND;
Tucci, A;
Nanji, T;
Pittman, A;
... Houlden, H; + view all
(2015)
The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism.
Neurobiol Aging
, 36
(2)
1221.e1 - 1221.e6.
10.1016/j.neurobiolaging.2014.08.024.
|
2014
Asi, YT;
Simpson, JE;
Heath, PR;
Wharton, SB;
Lees, AJ;
Revesz, T;
Houlden, H;
(2014)
Alpha-synuclein mRNA expression in oligodendrocytes in MSA.
Glia
, 62
(6)
pp. 964-970.
10.1002/glia.22653.
|
Aviles-Olmos, I;
Dickson, J;
Kefalopoulou, Z;
Djamshidian, A;
Kahan, J;
Ell, P;
Whitton, P;
... Foltynie, T; + view all
(2014)
Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.
Journal of Parkinson’s Disease
, 4
(3)
337 - 344.
10.3233/JPD-140364.
|
Bras, J;
Guerreiro, R;
Darwent, L;
Parkkinen, L;
Ansorge, O;
Escott-Price, V;
Hernandez, DG;
... Hardy, J; + view all
(2014)
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.
Hum Mol Genet
, 23
(23)
6139 - 6146.
10.1093/hmg/ddu334.
|
De Pablo-Fernandez, E;
Doherty, KM;
Holton, JL;
Revesz, T;
Djamshidian, A;
Limousin, P;
Bhatia, KP;
... Ling, H; + view all
(2014)
Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases.
J Neurol Neurosurg Psychiatry
10.1136/jnnp-2014-309460.
(In press).
|
Dunn, L;
Allen, GF;
Mamais, A;
Ling, H;
Li, A;
Duberley, KE;
Hargreaves, IP;
... Bandopadhyay, R; + view all
(2014)
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
Neurobiol Aging
, 35
(5)
pp. 1111-1115.
10.1016/j.neurobiolaging.2013.11.001.
|
Ling, H;
de Silva, R;
Massey, LA;
Courtney, R;
Hondhamuni, G;
Bajaj, N;
Lowe, J;
... Revesz, T; + view all
(2014)
Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
Neuropathol Appl Neurobiol
, 40
(2)
149 - 163.
10.1111/nan.12037.
|
Ling, H;
Kara, E;
Revesz, T;
Lees, AJ;
Plant, GT;
Martino, D;
Houlden, H;
... Holton, JL; + view all
(2014)
Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer.
Acta Neuropathol Commun
, 2
(1)
, Article 24. 10.1186/2051-5960-2-24.
|
Magdalinou, N;
Lees, AJ;
Zetterberg, H;
(2014)
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions.
Journal of Neurology, Neurosurgery & Psychiatry
, 85
(10)
pp. 1065-1075.
10.1136/jnnp-2013-307539.
|
Massey, LA;
(2014)
Clinical and radiological studies in PSP and related conditions.
Doctoral thesis , UCL (University College London).
|
Mencacci, NE;
Isaias, IU;
Reich, MM;
Ganos, C;
Plagnol, V;
Polke, JM;
Bras, J;
... on behalf of the International Parkinson’s Disease Genomics Cons; + view all
(2014)
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
Brain
, 137
(9)
pp. 2480-2492.
10.1093/brain/awu179.
|
Noyce, AJ;
Nagy, A;
Acharya, S;
Hadavi, S;
Bestwick, JP;
Fearnley, J;
Lees, AJ;
(2014)
Bradykinesia-Akinesia Incoordination Test: Validating an Online Keyboard Test of Upper Limb Function.
PLOS ONE
, 9
(4)
, Article ARTN e96260. 10.1371/journal.pone.0096260.
|
Torkamani, M;
McDonald, L;
Aguayo, IS;
Kanios, C;
Katsanou, MN;
Madeley, L;
Limousin, PD;
... Jahanshahi, M; + view all
(2014)
A Randomized Controlled Pilot Study to Evaluate a Technology Platform for the Assisted Living of People with Dementia and their Carers.
J Alzheimers Dis
, 41
(2)
pp. 515-523.
10.3233/JAD-132156.
|
Torsney, KM;
Noyce, AJ;
Doherty, KM;
Lees, AJ;
Bestwick, JP;
Dobson, R;
(2014)
Bone health in Parkinson's disease: A systematic review and meta-analysis.
Journal of Neurology, Neurosurgery and Psychiatry
, 85
(10)
pp. 1159-1166.
10.1136/jnnp-2013-307307.
|
Tsika, E;
Glauser, L;
Moser, R;
Fiser, A;
Daniel, G;
Sheerin, UM;
Lees, A;
... Moore, DJ; + view all
(2014)
Parkinson's Disease-Linked Mutations in VPS35 Induce Dopaminergic Neurodegeneration.
Hum Mol Genet
, 23
(17)
pp. 4621-4638.
10.1093/hmg/ddu178.
|
2013
Doherty, KM;
Davagnanam, I;
Molloy, S;
Silveira-Moriyama, L;
Lees, AJ;
(2013)
Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?
Journal of Neurology, Neurosurgery & Psychiatry
, 84
(12)
1400 -1403.
10.1136/jnnp-2012-304700.
|
Duran, R;
Mencacci, NE;
Angeli, AV;
Shoai, M;
Deas, E;
Houlden, H;
Mehta, A;
... Foltynie, T; + view all
(2013)
The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.
Movement Disorders
, 28
(2)
232 - 236.
10.1002/mds.25248.
|
Kiely, AP;
Asi, YT;
Kara, E;
Limousin, P;
Ling, H;
Lewis, P;
Proukakis, C;
... Holton, JL; + view all
(2013)
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?
Acta Neuropathologica
, 125
(5)
753 - 769.
10.1007/s00401-013-1096-7.
|
Klebe, S;
Golmard, JL;
Nalls, MA;
Saad, M;
Singleton, AB;
Bras, JM;
Hardy, J;
... Wood, NW; + view all
(2013)
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.
Journal of Neurology, Neurosurgery and Psychiatry
, 84
(6)
666 - 673.
10.1136/jnnp-2012-304475.
|
Li, A;
Paudel, R;
Johnson, R;
Courtney, R;
Lees, AJ;
Holton, JL;
Hardy, J;
... Houlden, H; + view all
(2013)
Pantothenate kinase-associated neurodegeneration is not a synucleinopathy.
Neuropathology and Applied Neurobiology
, 39
(2)
pp. 121-131.
10.1111/j.1365-2990.2012.01269.x.
|
Ling, H;
Kara, E;
Bandopadhyay, R;
Hardy, J;
Holton, J;
Xiromerisiou, G;
Lees, A;
... Revesz, T; + view all
(2013)
TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT.
Neurobiol Aging
, 34
(12)
2889.e5 - 2889.e9.
10.1016/j.neurobiolaging.2013.04.011.
|
Mamais, A;
Raja, M;
Manzoni, C;
Dihanich, S;
Lees, A;
Moore, D;
Lewis, PA;
(2013)
Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases.
Neurobiol Dis
, 58
pp. 183-190.
10.1016/j.nbd.2013.05.017.
|
Massey, LA;
Jäger, HR;
Paviour, DC;
O'Sullivan, SS;
Ling, H;
Williams, DR;
Kallis, C;
... Micallef, C; + view all
(2013)
The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.
Neurology
, 80
(20)
1856 - 1861.
10.1212/WNL.0b013e318292a2d2.
|
McNeill, A;
Wu, RM;
Tzen, KY;
Aguiar, PC;
Arbelo, JM;
Barone, P;
Bhatia, K;
... Schapira, AH; + view all
(2013)
Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.
PLOS ONE
, 8
(7)
, Article e69190. 10.1371/journal.pone.0069190.
|
Noyce, AJ;
Bestwick, JP;
Silveira-Moriyama, L;
Hawkes, CH;
Knowles, CH;
Hardy, J;
Giovannoni, G;
... Schrag, A; + view all
(2013)
PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results.
Journal of Neurology, Neurosurgery and Psychiatry
, 85
(1)
pp. 31-37.
10.1136/jnnp-2013-305420.
|
2012
Djamshidian, A;
O'Sullivan, SS;
Lees, A;
Averbeck, BB;
(2012)
Effects of dopamine on sensitivity to social bias in Parkinson's disease.
PLoS One
, 7
(3)
, Article e32889. 10.1371/journal.pone.0032889.
|
Kara, E;
Ling, H;
Pittman, AM;
Shaw, K;
de Silva, R;
Simone, R;
Holton, JL;
... Revesz, T; + view all
(2012)
The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features.
Neurobioly of Aging
, 33
(9)
2231.e7 - 2231.e14.
10.1016/j.neurobiolaging.2012.04.006.
|
Stockner, H;
Schwingenschuh, P;
Djamshidian, A;
Silveira-Moriyama, L;
Katschnig, P;
Seppi, K;
Dickson, J;
... Bhatia, KP; + view all
(2012)
Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?
Movement Disorders
, 27
(9)
1182 - 1185.
10.1002/mds.25102.
|
2011
Plagnol, V;
Nalls, MA;
Bras, JM;
Hernandez, DG;
Sharma, M;
Sheerin, UM;
Saad, M;
... WTCCC2; + view all
(2011)
A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease.
PLoS Genetics
, 7
(6)
, Article e1002142. 10.1371/journal.pgen.1002142.
|
2010
Silveira-Moriyama, L;
Azevedo, AMS;
Ranvaud, R;
Barbosa, ER;
Doty, RL;
Lees, AJ;
(2010)
Applying a new version of the Brazilian-Portuguese UPSIT smell test in Brazil.
ARQ NEURO-PSIQUIAT
, 68
(5)
700 - 705.
10.1590/S0004-282X2010000500005.
|
2009
Andrade, LAF;
Selikhova, M;
Lees, AJ;
(2009)
Konstantin N. Tretiakoff in Brazil a historical perspective and discussion of his contribution to Brazilian neuroscience.
Arquivos de Neuro-Psiquiatria
, 67
(2A)
322 - 327.
10.1590/S0004-282X2009000200032.
|
2004
Emre, M.;
Aarsland, D.;
Albanese, A.;
Byrne, E.J.;
Deuschl, G.;
De Deyn, P.P.;
Durif, F.;
... Lane, R.; + view all
(2004)
Rivastigmine for dementia associated with Parkinson's disease.
New England Journal of Medicine
, 351
(24)
pp. 2509-2518.
10.1056/NEJMoa041470.
|